- Home
- INKT vs NEUE Comparison
INKT vs NEUE Comparison
Compare INKT & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- NEUE
- Stock Information
- Founded
- INKT 2017
- NEUE 2015
- Country
- INKT United States
- NEUE United States
- Employees
- INKT N/A
- NEUE N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- NEUE
- Sector
- INKT Health Care
- NEUE
- Exchange
- INKT Nasdaq
- NEUE NYSE
- Market Cap
- INKT 75.7M
- NEUE 61.3M
- IPO Year
- INKT 2021
- NEUE 2021
- Fundamental
- Price
- INKT $17.18
- NEUE $6.83
- Analyst Decision
- INKT Hold
- NEUE Hold
- Analyst Count
- INKT 3
- NEUE 1
- Target Price
- INKT $37.50
- NEUE $7.00
- AVG Volume (30 Days)
- INKT 2.9M
- NEUE 5.0K
- Earning Date
- INKT 08-12-2025
- NEUE 08-07-2025
- Dividend Yield
- INKT N/A
- NEUE N/A
- EPS Growth
- INKT N/A
- NEUE N/A
- EPS
- INKT N/A
- NEUE N/A
- Revenue
- INKT N/A
- NEUE $907,349,000.00
- Revenue This Year
- INKT N/A
- NEUE $33.99
- Revenue Next Year
- INKT N/A
- NEUE $5.90
- P/E Ratio
- INKT N/A
- NEUE N/A
- Revenue Growth
- INKT N/A
- NEUE N/A
- 52 Week Low
- INKT $4.56
- NEUE $3.79
- 52 Week High
- INKT $76.00
- NEUE $7.66
- Technical
- Relative Strength Index (RSI)
- INKT 51.36
- NEUE 44.73
- Support Level
- INKT $18.38
- NEUE $6.70
- Resistance Level
- INKT $20.25
- NEUE $6.88
- Average True Range (ATR)
- INKT 8.07
- NEUE 0.09
- MACD
- INKT -1.01
- NEUE -0.01
- Stochastic Oscillator
- INKT 16.15
- NEUE 29.92
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About NEUE NEUEHEALTH INC
NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.